Skip to main content

Table 1 Baseline characteristics, 1-year weight change and 4-year serum adiponectin change in DPS participants.

From: Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study

Sex (male/female)

 

166/341

Age (y)

 

55.33 ± 7.06 (507)

Weight (kg)

 

86.20 ± 14.19 (507)

BMI (kg/m2)

 

31.25 ± 4.54 (507)

Waist circumference (cm)

 

101.22 ± 10.99 (505)

Fasting plasma glucose (mmol/l)

 

6.14 ± 0.75 (507)

2-h plasma glucose (mmol/l)

 

8.88 ± 1.49 (507)

Fasting serum insulin (mU/l)

 

14.77 ± 7.40 (461)

2-h serum insulin (mU/l)

 

95.17 ± 65.10 (458)

Serum adiponectin (μg/ml)

 

8.47 ± 3.74 (237)

1-year weight change (kg)

 

-2.736 ± 4.723 (506)

 

Intervention group

-4.465 ± 4.976 (256)

 

Control group

-0.965 ± 3.695 (250)

4-year adiponectin change (μg/ml)

 

0.015 ± 2.135 (190)

 

Intervention group

0.091 ± 2.245 (97)

 

Control group

-0.063 ± 2.203 (93)

  1. Values are mean ± SD (N); BMI, Body Mass Index